GFR-estimating models in kidney transplant recipients on a steroid-free regimen.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 2910331)

Published in Nephrol Dial Transplant on January 29, 2010

Authors

Aleksandra Kukla1, Yasser El-Shahawi, Erin Leister, Bertram Kasiske, Michael Mauer, Arthur Matas, Hassan N Ibrahim

Author Affiliations

1: Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA ibrah007@umn.edu

Associated clinical trials:

NCT 00067990

Articles cited by this

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol (2005) 2.67

Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol (1975) 1.83

MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant (2005) 1.82

Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64

Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int (2005) 1.62

Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol (2002) 1.43

Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review. Am J Kidney Dis (2008) 1.20

Chronic kidney disease stage in renal transplantation classification using cystatin C and creatinine-based equations. Nephrol Dial Transplant (2007) 0.89

Determinants of short-term changes in body composition following renal transplantation. Scand J Urol Nephrol (2009) 0.86

Overestimation of renal function in glucocorticosteroid treated patients. Eur J Clin Pharmacol (1985) 0.84

Limitations of glomerular filtration rate equations in the renal transplant patient. Clin Transplant (2005) 0.83

Evaluation of renal function in transplantation. Transplantation (2007) 0.82

Creatinine excretion after renal transplantation. Transplantation (1989) 0.82

Articles by these authors

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation (2006) 3.24

US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81

US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis (2009) 2.43

Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 2.28

Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16

Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes (2003) 2.16

United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14

Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Ann Intern Med (2015) 2.13

Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes (2007) 2.08

Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01

National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01

An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int (2002) 1.80

The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes (2002) 1.79

Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol (2013) 1.77

Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes (2002) 1.70

Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70

Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol (2012) 1.69

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67

A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest (2010) 1.61

Histopathology of diabetic nephropathy. Semin Nephrol (2007) 1.60

A prospective controlled study of kidney donors: baseline and 6-month follow-up. Am J Kidney Dis (2013) 1.55

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes (2005) 1.40

Medical outcomes of adolescent live kidney donors. Pediatr Transplant (2014) 1.40

Promotion of altruistic donation: a reply. Transplantation (2010) 1.40

Podocyte structural parameters do not predict progression to diabetic nephropathy in normoalbuminuric type 1 diabetic patients. Am J Nephrol (2015) 1.39

Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes (2005) 1.34

Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant (2009) 1.28

Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int (2010) 1.25

Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin J Am Soc Nephrol (2010) 1.24

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrol Dial Transplant (2011) 1.23

Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol (2003) 1.21

Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis (2006) 1.18

Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant (2005) 1.17

Diabetes and nephropathy. Curr Opin Nephrol Hypertens (2003) 1.16

Glomerulotubular junction abnormalities are associated with proteinuria in type 1 diabetes. J Am Soc Nephrol (2006) 1.16

Urinary beta2-microglobulin is associated with acute renal allograft rejection. Am J Kidney Dis (2006) 1.15

Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol (2006) 1.14

Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med (2010) 1.13

Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol (2003) 1.10

Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol (2002) 1.09

Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09

Predictors of graft failure and death in elderly kidney transplant recipients. Transplantation (2013) 1.05

The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. Am J Kidney Dis (2003) 1.04

Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl (2012) 1.04

Comparison of methods for counting cells in the mouse glomerulus. Nephron Exp Nephrol (2006) 1.03

Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection. AIDS Care (2013) 1.03

Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol (2013) 1.02

Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol (2013) 1.01

Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nat Rev Nephrol (2010) 1.01

Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. Transplantation (2007) 1.01

Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes (2002) 1.00

Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes (2003) 0.99

Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-affected adolescents. AIDS Behav (2010) 0.99

A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97

Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr Endocrinol Rev (2008) 0.97

Fabry disease: dose matters. J Am Soc Nephrol (2014) 0.97

Approach to the patient with type 2 diabetes and progressive kidney disease. J Clin Endocrinol Metab (2010) 0.96

Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol (2008) 0.96

The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology (2006) 0.96

The unjustified classification of kidney donors as patients with CKD: critique and recommendations. Clin J Am Soc Nephrol (2013) 0.95

Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation (2006) 0.95

Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth. AIDS (2010) 0.95

Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents. Clin Immunol (2011) 0.94

Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report. Transplantation (2005) 0.93

Renal complications of Fabry disease in children. Pediatr Nephrol (2012) 0.93

Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways. Diabetes (2006) 0.92

Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection. Transplantation (2008) 0.91

Effects of sex on renal structure. Nephron (2002) 0.91

Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results. Transplantation (2009) 0.91

Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90

Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care (2013) 0.90

Appraisal of GFR-estimating equations following kidney donation. Am J Kidney Dis (2009) 0.90

Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract (2008) 0.89

Gene expression differences in skin fibroblasts in identical twins discordant for type 1 diabetes. Diabetes (2012) 0.89

Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis. AIDS (2014) 0.88

Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors. Eur J Clin Pharmacol (2008) 0.88

Cardiac biomarkers in HIV-exposed uninfected children. AIDS (2013) 0.88

Long-term outcomes of kidney donors. Curr Opin Nephrol Hypertens (2011) 0.87

Long-term outcomes of kidney donors. Curr Opin Nephrol Hypertens (2010) 0.87

Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome. Transplantation (2008) 0.86

Surrogate markers for long-term renal allograft survival. Am J Transplant (2004) 0.85

Kidney transplant patients' perceptions, beliefs, and barriers related to regular nephrology outpatient visits. Am J Kidney Dis (2010) 0.84

Assessment of renal pathology and dysfunction in children with Fabry disease. Clin J Am Soc Nephrol (2010) 0.84

Estimating mean glomerular volume using two arbitrary parallel sections. J Am Soc Nephrol (2002) 0.83

Studying multiple protein profiles over time to assess biomarker validity. Expert Rev Proteomics (2006) 0.83

Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients. Diabetes (2008) 0.83

Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications (2012) 0.83

Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse? Curr Opin Organ Transplant (2009) 0.83

Temporal profile of diabetic nephropathy pathologic changes. Curr Diab Rep (2013) 0.83